At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Posted on: 29 May, 2025
International Clinical Trials Day provided the chance to recognise the many people contributing to o..... Read more
Category: New Treatment, Research Excellence
Posted on: 23 May, 2025
Check out our latest newsletter Researchers target sleep for muscle pain relief Landmark clinical t..... Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research, Newsletters, Research Excellence, World-leading technology
Posted on: 15 May, 2025
Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben So..... Read more
Category: Funding support, Research Excellence